AzTrials
AzTrials

PCOS (Polycystic Ovary Syndrome) of Bilateral OvariesNCT05880550

PCOS and US Cavitation

A study testing ultrasound cavitation in addition to aerobic ex and aerobic exercises. in people with PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries, run by Cairo University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age. Women with this syndrome may have infrequent menstrual periods or amenorrhea and excess androgen levels. Read more about this study

Who is it for?
Ages 20 to 35 years, women only
What is being tested?
ultrasound cavitation in addition to aerobic ex and aerobic exercises.
Could I receive a placebo?
No, everyone receives an active treatment
How many people
60 participants
Where
1 siteEgypt
Study dates
25 May 2023to 25 Sep 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 35 years
  • Women only
  • No healthy volunteers
  • Adult

Who may be able to join

  • All women in this study will be on the following criteria:
  • Their ages will range from 20-35 years.
  • They will be diagnosed with PCOS by Gynecologist.
  • Doesn't receive any treatment for menstrual regularity and fertility during the study.
  • BMI above 25kg/m²and less than 35kg/m².
  • Waist /hip ratio <.88.

Who cannot join

  • Women will be excluded if they have one of the following criteria:
  • Skin diseases that prevent the application of cavitation.
  • Severe cardiovascular disease.
  • Other endocrine disordered (hypothyroidism hyperprolactinemia).
  • Patients that who take hormonal treatment within the last 3 months before the study.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Marwa Shafiek Saleh

    Giza, 12613

Other trials in Egypt

About this study

Official title: Response of Menstrual Irregularity and Infertility- Related Stress to Ultrasound Cavitation Combined With Aerobic Exercise in PCOS: Double Blinded Randomized Controlled Trial

Polycystic ovary syndrome (PCOS) is the most common endocrine disorder in women of reproductive age. Women with this syndrome may have infrequent menstrual periods or amenorrhea and excess androgen levels. The ovaries develop numerous small follicles and fail to ovulate on a regular basis, with subsequent subfertility in those women that wish to conceive. Recent research stated that interventions aiming to improve QoL among infertile women with PCOS should focus on alleviating infertility-related stress, especially among women with high BMI. So, the purpose of this study is to investigate the effect of ultrasound cavitation combined with aerobic exercise on menstrual irregularity and infertility related stress in women having PCOS.

Being tested
ultrasound cavitation in addition to aerobic ex, aerobic exercises.
Medical subject headings
Polycystic Ovary Syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • ultrasound cavitation in addition to aerobic exOther

    Ultrasonic cavitation was turned on, the program of cavitation 40 kHz was chosen, the time was adjusted at 30 minutes. The cavitational head was moved very slowly on each abdominal segment in a small circular movement for 5 minutes. After finishing the focused ultrasound of the 6 segments of the abdomen, the skin was cleaned with cotton.

    in addition to that the patients will receive aerobic exercises for 40 minutes.

  • aerobic exercises.Other

    the patients will do aerobic training for 40 minutes on a bicycle ergometer.

Study groups in NCT05880550
Study groupRoleWhat they receive
study groupExperimentalNot described
Receives: Other: ultrasound cavitation in addition to aerobic ex
control groupActive comparatorNot described
Receives: Other: aerobic exercises.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Infertily related Stress level

    Infertility-Related Stress Scale is a concise, reliable, and validated tool; it facilitates quick screening for infertility's impact on intrapersonal and interpersonal life domains. The IRSS consists of 12 items rated from 1 ("no stress") to 7 ("high stress")., with higher grades means higher stress.

    Measured: change from base line at 12 weeks.

  2. cortisol level

    Saliva samples will be collected with study participants sitting upright in a comfortable position and tilting the head forward, allowing the saliva to pool on the floor of the mouth

    Measured: change from base line at 12 weeks.

Secondary outcomes (2)
  1. Anthrometric measurement (body mass index and waist-hip ratio)

    BMI and waist/hip ratio Measurements of body mass index in which the weight in kilograms divided by the square of the heights in meters and waist to hip circumference measured with a soft tape at the level of the umbilicus and the anterior superior iliac spine with woman in the standing position, were made before treatment and after the end of the study period

    Measured: change from base line at 12 weeks.

  2. Hormonal profile

    Blood samples will be drown from an antecubital vein of each patient in the study on two occasions, firstly at the end at 2 nd or 3 rd day of the menstrual cycle after an overnight fasting just before starting her treatment regimen and secondly after 3 months of the treatment. It will be centrifuged within 2 hours after withdrawal. Serum will be stared at -20OC and assayed for LH and FSH with chemiluminescent enzyme immunoassay kits. Assays for fasting insulin by RIA kits and SHBG will be determined by using an immunoradiometric assay (IRMA).

    Measured: change from base line at 12 weeks.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted30 May 2023
  2. Study start25 May 2023
  3. Primary completion25 Aug 2023
  4. Study completion25 Sep 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
60 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05880550
Sponsor's protocol ID
US cavitation and PCOS
Status last verified
May 2024
First submitted
19 May 2023
Last updated
14 May 2024
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing ultrasound cavitation in addition to aerobic ex and aerobic exercises. in people with PCOS (Polycystic Ovary Syndrome) of Bilateral Ovaries, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 May 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Infertily related Stress level (time frame: change from base line at 12 weeks.). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 May 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in